World Journal of Gastroenterology 2023;29:17791794
Members receive protocol updates, comparative analyses, and practical guidance for evaluating emerging options as they become available
277 The reported variation in the weight loss for the different GLP-1 analogues currently used to treat T2D is possibly related to their ability to penetrate the CNS, allowing for central GLP-1R binding
Scott Brunner, CEO of the Alliance for Pharmacy Compounding, a group representing pharmacies that make compounded drugs, noted in a post on LinkedIn that While adverse events do sometimes occur, as they do with FDA-approved drugs as well, legitimate compounding pharmacies operate in a compliance framework in which ensuring patient safety is both paramount and essential to the pharmacys ability to continue to serve its patients. Last month, the FDA said the shortage of tirzepatide, sold by Eli Lilly as Mounjaro for diabetes and Zepbound for obesity, had been resolved, which was expected to lead to the end of mass compounding of the medicine
Data availability The numerical source data underlying the graphs and charts presented in this study are provided in the Source Data file
Updated weekly, Scripta's GLP-1 Navigator helps members understand their options and the trade-offsregardless of whether their plan covers GLP-1sincluding guidance around: Brand/formulation differences Delivery methods and side effects Cash pay vs
